Zhao Jing-Jie, Wang Xi-Bing, Luan Yun, Liu Jun-Li, Liu Ling, Jia Hong-Ying
Clinical Molecular Biology Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.
Department of Gynaecology and Obstetrics, Maternal and Child Health Care Service Center of Zaozhuang, Shandong 277102, P.R. China.
Biomed Rep. 2013 Sep;1(5):751-756. doi: 10.3892/br.2013.152. Epub 2013 Jul 22.
The aim of the present study was to investigate the association of human leukocyte antigen (HLA) gene polymorphism and clinical phenotypes of patients with mesangial proliferative glomerulonephritis (MsPGN). The genotyping of HLA-A, HLA-B and HLA-DRB1 alleles was detected in 1,536 consecutive MsPGN patients during the previous five years and 2,027 age- and gender-matched healthy individuals by using the polymerase chain reaction-sequence-specific primers method. The clinical and pathological data of the patients were collected and the genotype frequencies (GF) and odds ratio (OR) were analyzed. The allele frequencies of HLA-A23, A25, B15, B40, B53 and DRB118 were significantly higher in MsPGN patients than in the controls (P<0.05). These alleles were considered as the suspected susceptibility genes (SSG) for MsPGN. Of note, results of the follow-up survey study demonstrated poorer prognosis of patients with SSG than those without SSG. On the other hand, the frequencies of A32, A33, B50, B58, B60, B71, DRB116 were lower in MsPGN patients than in the controls (P<0.05). However, the alleles A20, A22, A35, A36, A38, B21, B73 and B*78 were not expressed in MsPGN patients. HLA gene polymorphism is associated with hereditary susceptibility to MsPGN. Therefore, there might be corresponding susceptibility and protective genes associated with MsPGN.
本研究旨在探讨人类白细胞抗原(HLA)基因多态性与系膜增生性肾小球肾炎(MsPGN)患者临床表型之间的关联。采用聚合酶链反应-序列特异性引物法,对过去五年中连续收治的1536例MsPGN患者及2027例年龄、性别匹配的健康个体进行HLA-A、HLA-B和HLA-DRB1等位基因的基因分型检测。收集患者的临床和病理资料,并分析基因型频率(GF)和比值比(OR)。MsPGN患者中HLA-A23、A25、B15、B40、B53和DRB118的等位基因频率显著高于对照组(P<0.05)。这些等位基因被认为是MsPGN的疑似易感基因(SSG)。值得注意的是,随访调查研究结果显示,携带SSG的患者预后较未携带SSG的患者差。另一方面,MsPGN患者中A32、A33、B50、B58、B60、B71、DRB116的频率低于对照组(P<0.05)。然而,等位基因A20、A22、A35、A36、A38、B21、B73和B*78在MsPGN患者中未表达。HLA基因多态性与MsPGN的遗传易感性相关。因此,可能存在与MsPGN相关的相应易感基因和保护基因。